---
figid: PMC9332003__ijms-23-08144-g004
pmcid: PMC9332003
image_filename: ijms-23-08144-g004.jpg
figure_link: /pmc/articles/PMC9332003/figure/ijms-23-08144-f004/
number: Figure 4
figure_title: ''
caption: EPO regulates serotonin receptors and neuroinflammation at mRNA levels in
  the hippocampus. (A–D) Serotonin; 5-hydroxytryptamine (5-HT) receptors and neuroinflammation-related
  factors, such as (E) TNF-α, (F) NLRP3, (G) TLR4, and (H) FAS, were regulated by
  EPO. n = 6 per group. * p < 0.05, ** p < 0.01, *** p < 0.005, and **** p < 0.0001
  according to independent t-test in (A–H).
article_title: Therapeutic Effect of Erythropoietin on Alzheimer’s Disease by Activating
  the Serotonin Pathway.
citation: Kyu-Ho Shim, et al. Int J Mol Sci. 2022 Aug;23(15):8144.
year: '2022'

doi: 10.3390/ijms23158144
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI

keywords:
- therapeutics
- erythropoietin
- serotonin
- Alzheimer’s disease
- amyloid beta-peptides
- cognitive dysfunction

---
